5-methoxytryptamine has been researched along with Cardiovascular Diseases in 1 studies
5-Methoxytryptamine: Serotonin derivative proposed as potentiator for hypnotics and sedatives.
5-methoxytryptamine : A member of the class of tryptamines that is the methyl ether derivative of serotonin.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mao, H | 1 |
| Zhang, Y | 1 |
| Wang, L | 1 |
| Zhou, A | 1 |
| Zhang, S | 1 |
| Cao, J | 1 |
| Xia, H | 1 |
1 other study available for 5-methoxytryptamine and Cardiovascular Diseases
| Article | Year |
|---|---|
Cyclopeptide-β-cyclodextrin/γ-glycerol methoxytrimethoxysilane film for potential vascular tissue engineering scaffolds.
Topics: 5-Methoxytryptamine; beta-Cyclodextrins; Calorimetry, Differential Scanning; Cardiovascular Diseases | 2022 |